Study aims to unlock equal access to cancer trials for all

NCT ID NCT07342335

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at why certain groups of cancer patients—such as those from minority backgrounds or lower-income areas—are less likely to take part in research. By surveying 300 patients and mapping where they live, the team hopes to identify barriers and improve access. The goal is to make clinical trials more inclusive and representative of the whole community.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could help design better outreach programs so that more cancer patients from all backgrounds can join research studies.

What could go wrong

This is an observational study, not a treatment trial. It may identify barriers but won't directly improve health outcomes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

cancer neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Clatterbridge Cancer Centre

    RECRUITING

    Liverpool, L7 8YA, United Kingdom

    Contact Phone: •••-•••-•••• Email: •••••@•••••